|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0013227,
umls-concept:C0028840,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0205421,
umls-concept:C0332162,
umls-concept:C0332237,
umls-concept:C0339573,
umls-concept:C0597128,
umls-concept:C1292733,
umls-concept:C1522168
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-6-6
|
|
pubmed:abstractText |
Primary open-angle glaucoma (POAG) is one of the leading causes of blindness in the United States and worldwide. Three to 6 million people in the United States are at increased risk for developing POAG because of elevated intraocular pressure (IOP), or ocular hypertension. There is no consensus on the efficacy of medical treatment in delaying or preventing the onset of POAG in individuals with elevated IOP. Therefore, we designed a randomized clinical trial, the Ocular Hypertension Treatment Study.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0003-9950
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
120
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
701-13; discussion 829-30
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12049574-Administration, Topical,
pubmed-meshheading:12049574-Adult,
pubmed-meshheading:12049574-Aged,
pubmed-meshheading:12049574-Aged, 80 and over,
pubmed-meshheading:12049574-Antihypertensive Agents,
pubmed-meshheading:12049574-Double-Blind Method,
pubmed-meshheading:12049574-Female,
pubmed-meshheading:12049574-Follow-Up Studies,
pubmed-meshheading:12049574-Glaucoma, Open-Angle,
pubmed-meshheading:12049574-Humans,
pubmed-meshheading:12049574-Intraocular Pressure,
pubmed-meshheading:12049574-Male,
pubmed-meshheading:12049574-Middle Aged,
pubmed-meshheading:12049574-Ocular Hypertension,
pubmed-meshheading:12049574-Ophthalmic Solutions,
pubmed-meshheading:12049574-Optic Disk,
pubmed-meshheading:12049574-Patient Compliance,
pubmed-meshheading:12049574-Safety,
pubmed-meshheading:12049574-Treatment Outcome,
pubmed-meshheading:12049574-Visual Acuity,
pubmed-meshheading:12049574-Visual Fields
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
|
|
pubmed:affiliation |
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO 63110, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
